Characterization of neutralizing antibodies to West Nile virus.

Melissa D SánchezRobert W Doms


We produced nine monoclonal antibodies (MAbs) directed against the West Nile virus E glycoprotein using three different immunization strategies: inactivated virus, naked DNA, and recombinant protein. Most of the MAbs bound to conformation dependent epitopes in domain III of the E protein. Four of the MAbs neutralized WNV infection and bound to the same region of domain III with high affinity. The neutralizing MAbs were obtained from mice immunized with inactivated virus alone or in combination with a DNA plasmid. In contrast, MAbs obtained by immunization with a soluble version of the E glycoprotein did not exhibit neutralizing activity. These non-neutralizing antibodies were cross-reactive with several other flaviviruses, including Saint Louis encephalitis, Japanese encephalitis, Yellow Fever and Powassan viruses. Interestingly, some non-neutralizing MAbs bound with high affinity to domains I or III, indicating that both affinity and the precise epitope recognized by an antibody are important determinants of WNV neutralization.


Feb 1, 1991·Immunology and Cell Biology·R A HallP Clancy
Jan 1, 1988·Archives of Virology·T G Besselaar, N K Blackburn
Feb 1, 1982·The Journal of General Virology·J S PeirisJ T Roehrig
Sep 1, 1995·Trends in Biochemical Sciences·R A Sayle, E J Milner-White
Mar 30, 2001·Virology·V F YamshchikovR W Compans
Oct 5, 2001·Emerging Infectious Diseases·Z ShimoniS Bulvik
Mar 22, 2002·Journal of Virology·Karin StiasnyFranz X Heinz
Aug 20, 2002·The Journal of General Virology·P J Klasse, Q J Sattentau
Nov 8, 2002·Transplant Infectious Disease : an Official Journal of the Transplantation Society·A HamdanM Weinberger
May 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·Yorgo ModisStephen C Harrison
May 30, 2003·The EMBO Journal·Ying ZhangMichael G Rossmann
Jun 26, 2003·The Journal of Infectious Diseases·Amy Guillet Agrawal, Lyle R Petersen
Jun 26, 2003·The Journal of Infectious Diseases·David Ben-NathanBracha Rager-Zisman
Sep 5, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michael HaleyNaomi P O'Grady
Oct 11, 2003·Science·Suchetana MukhopadhyayRichard J Kuhn
Nov 26, 2003·Antiviral Research·Aysegul NalcaChris A Whitehouse

❮ Previous
Next ❯


Sep 24, 2013·BioMed Research International·Giuseppe SauttoRoberto Burioni
Mar 7, 2014·Viruses·S Kyle Austin, Kimberly A Dowd
Aug 10, 2006·Proceedings of the National Academy of Sciences of the United States of America·Bärbel KaufmannMichael G Rossmann
Feb 27, 2014·Molecular Biotechnology·Indulis CielensRegina Renhofa
Jan 18, 2006·Journal of Virology·Carl W DavisTheodore C Pierson
Sep 22, 2006·Journal of Virology·Grant E NybakkenDaved H Fremont
Aug 24, 2007·Journal of Virology·Theodore OliphantMichael S Diamond
Oct 27, 2009·The Journal of Clinical Investigation·Marion C LanteriPhilip J Norris
Mar 25, 2010·PLoS Pathogens·Wahala M P B WahalaAravinda M de Silva
Oct 20, 2010·Proceedings of the National Academy of Sciences of the United States of America·Bärbel KaufmannMichael G Rossmann
Feb 23, 2012·Viruses·Wahala M P B Wahala, Aravinda M de Silva
Apr 17, 2012·Virology Journal·Davide LelliPaolo Cordioli
Nov 15, 2013·International Journal of Environmental Research and Public Health·Cécile BeckSylvie Lecollinet
Dec 10, 2013·International Journal of Environmental Research and Public Health·Andriani MarkaGeorgios Eleftheriou
Jan 15, 2008·The Journal of Infectious Diseases·Michel LedizetRaymond A Koski
Apr 22, 2008·The Journal of Infectious Diseases·Marion C LanteriPhilip J Norris
Apr 12, 2013·Virologica Sinica·Zhongyu ZhuDimiter S Dimitrov
Jan 31, 2006·Expert Review of Anti-infective Therapy·Zhongyu ZhuDimiter S Dimitrov
Nov 26, 2005·Expert Review of Anti-infective Therapy·Michael S Diamond
Feb 9, 2012·Expert Review of Vaccines·Mario Lobigs, Michael S Diamond
Jun 9, 2007·Expert Opinion on Biological Therapy·Theodore Oliphant, Michael S Diamond
Sep 8, 2010·Biologicals : Journal of the International Association of Biological Standardization·Juliana Helena ChávezLuiz Tadeu Moraes Figueiredo
Sep 16, 2008·Comparative Immunology, Microbiology and Infectious Diseases·Shumpei WatanabeHiroomi Akashi
Jun 10, 2008·Trends in Molecular Medicine·Robyn S Klein, Michael S Diamond
Jul 1, 2008·Antiviral Research·Rushika PereraRichard J Kuhn
Oct 8, 2008·Immunological Reviews·Michael S DiamondDaved H Fremont

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Barrett Esophagus

Barrett’s esophagus if a serious complication of gastroesophageal reflux disease during which the normal esophageal lining changes to tissue that resembles intestinal lining. Here is the latest research.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.